Influence of COVID-19 pandemic on pregnancy and fertility preferences among the residents of the United Arab Emirates (UAE).

Autor: Ganesan S; G42 Healthcare, Abu Dhabi, United Arab Emirates.; Insights Research Organization and Solutions (IROS), Abu Dhabi, United Arab Emirates., Al Ketbi LM; Ambulatory Healthcare Services, SEHA, Abu Dhabi, United Arab Emirates., Cantarutti FM; G42 Healthcare, Abu Dhabi, United Arab Emirates.; Insights Research Organization and Solutions (IROS), Abu Dhabi, United Arab Emirates., Al Kaabi N; Ambulatory Healthcare Services, SEHA, Abu Dhabi, United Arab Emirates., Al Mansoori M; United Arab Emirates University, Abu Dhabi, United Arab Emirates., Al Saedi MR; Ambulatory Healthcare Services, SEHA, Abu Dhabi, United Arab Emirates., Al Blooshi FI; Ambulatory Healthcare Services, SEHA, Abu Dhabi, United Arab Emirates., Al Nuaimi RA; Ambulatory Healthcare Services, SEHA, Abu Dhabi, United Arab Emirates., Ibrahim M; Insights Research Organization and Solutions (IROS), Abu Dhabi, United Arab Emirates., Eltantawy I; Insights Research Organization and Solutions (IROS), Abu Dhabi, United Arab Emirates., Al Marzooqi F; G42 Healthcare, Abu Dhabi, United Arab Emirates., Zaher WA; G42 Healthcare, Abu Dhabi, United Arab Emirates.; Insights Research Organization and Solutions (IROS), Abu Dhabi, United Arab Emirates.; United Arab Emirates University, Abu Dhabi, United Arab Emirates.; Khalifa University, Abu Dhabi, United Arab Emirates.

Publikováno v: Journal of global health [J Glob Health] 2024 Feb 09; Vol. 14, pp. 05002. Date of Electronic Publication: 2024 Feb 09.

Durability of antibodies post vaccination with two doses of inactivated BBIBP-CorV vaccine.

Autor: Mahmoud S; Biogenix Lab, Abu Dhabi, UAE., Ganesan S; G42 Healthcare, Abu Dhabi, UAE.; IROS (Insights Research Organization and Solutions), Abu Dhabi, UAE., Sharif-Askari NS; College of Medicine, University of Sharjah, Sharjah, UAE., Cantarutti F; G42 Healthcare, Abu Dhabi, UAE.; IROS (Insights Research Organization and Solutions), Abu Dhabi, UAE., Wilson H; IROS (Insights Research Organization and Solutions), Abu Dhabi, UAE., Ogrodzki P; G42 Healthcare, Abu Dhabi, UAE., Halwani R; College of Medicine, University of Sharjah, Sharjah, UAE., Alkaabi N; Sheikh Khalifa Medical City SEHA, Abu Dhabi, UAE.; College of Medicine and Health Sciences, Khalifa University, Abu Dhabi, UAE., Zaher WA; G42 Healthcare, Abu Dhabi, UAE.; IROS (Insights Research Organization and Solutions), Abu Dhabi, UAE.; College of Medicine and Health Sciences, Khalifa University, Abu Dhabi, UAE.; College of Medicine and Health Sciences, United Arab Emirates University, UAE.

Publikováno v: Current medical research and opinion [Curr Med Res Opin] 2022 Dec; Vol. 38 (12), pp. 2069-2075. Date of Electronic Publication: 2022 Nov 07.

An analysis of antibody responses and clinical sequalae of the Sinopharm HB02 COVID19 vaccine in dialysis patients in the United Arab Emirates.

Autor: Holt SG; SEHA Kidney Care, SEHA-Abu Dhabi Health Services Company, Abu Dhabi, UAE.; Department of Medicine, Khalifa University, Abu Dhabi, UAE., Mahmoud S; G42, Group 42, Abu Dhabi, UAE., Ahmed W; SEHA Kidney Care, SEHA-Abu Dhabi Health Services Company, Abu Dhabi, UAE., Acuna JM; SEHA Kidney Care, SEHA-Abu Dhabi Health Services Company, Abu Dhabi, UAE.; Department of Medicine, Khalifa University, Abu Dhabi, UAE., Al Madani AK; SEHA Kidney Care, SEHA-Abu Dhabi Health Services Company, Abu Dhabi, UAE., Eltantawy I; G42, Group 42, Abu Dhabi, UAE., Zaher WA; G42, Group 42, Abu Dhabi, UAE., Goodier GJ; Abu Dhabi Health Services Company, Abu Dhabi, UAE., Al Kaabi NA; Sheikh Khalifa Medical City, SEHA-Abu Dhabi Health Services Company, Abu Dhabi, UAE., Al Obaidli AA; SEHA Kidney Care, SEHA-Abu Dhabi Health Services Company, Abu Dhabi, UAE.; Department of Medicine, Khalifa University, Abu Dhabi, UAE.

Publikováno v: Nephrology (Carlton, Vic.) [Nephrology (Carlton)] 2022 Mar; Vol. 27 (3), pp. 260-268. Date of Electronic Publication: 2021 Oct 05.

Publisher Correction: Genomic epidemiology of SARS-CoV-2 in the UAE reveals novel virus mutation, patterns of co-infection and tissue specific host immune response.

Autor: Liu R; Group42 Healthcare, Abu Dhabi, United Arab Emirates.; BGI-Shenzhen, Shenzhen, 518083, Guangdong, China., Wu P; Group42 Healthcare, Abu Dhabi, United Arab Emirates.; BGI-Shenzhen, Shenzhen, 518083, Guangdong, China., Ogrodzki P; Group42 Healthcare, Abu Dhabi, United Arab Emirates., Mahmoud S; Group42 Healthcare, Abu Dhabi, United Arab Emirates., Liang K; MGI, BGI-Shenzhen, Shenzhen, 518083, Guangdong, China., Liu P; MGI, BGI-Shenzhen, Shenzhen, 518083, Guangdong, China., Francis SS; Department of Neurological Surgery, University of California, San Francisco, USA.; Department of Epidemiology and Biostatistics, University of California, San Francisco, USA., Khalak H; Group42 Healthcare, Abu Dhabi, United Arab Emirates., Liu D; Laboratory of Health Intelligence, Huawei Technologies Co., Ltd., Shenzhen, 518100, China., Li J; BGI-Shenzhen, Shenzhen, 518083, Guangdong, China.; Shenzhen Key Laboratory of Unknown Pathogen Identification, BGI-Shenzhen, Shenzhen, 518083, China., Ma T; MGI, BGI-Shenzhen, Shenzhen, 518083, Guangdong, China., Chen F; MGI, BGI-Shenzhen, Shenzhen, 518083, Guangdong, China., Liu W; BGI-Shenzhen, Shenzhen, 518083, Guangdong, China., Huang X; MGI, BGI-Shenzhen, Shenzhen, 518083, Guangdong, China., He W; Laboratory of Health Intelligence, Huawei Technologies Co., Ltd., Shenzhen, 518100, China., Yuan Z; Laboratory of Health Intelligence, Huawei Technologies Co., Ltd., Shenzhen, 518100, China., Qiao N; Laboratory of Health Intelligence, Huawei Technologies Co., Ltd., Shenzhen, 518100, China., Meng X; Laboratory of Health Intelligence, Huawei Technologies Co., Ltd., Shenzhen, 518100, China., Alqarni B; Group42 Healthcare, Abu Dhabi, United Arab Emirates., Quilez J; Group42 Healthcare, Abu Dhabi, United Arab Emirates., Kusuma V; Group42 Healthcare, Abu Dhabi, United Arab Emirates., Lin L; BGI-Shenzhen, Shenzhen, 518083, Guangdong, China., Jin X; BGI-Shenzhen, Shenzhen, 518083, Guangdong, China., Yang C; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, USA., Anton X; Group42 Healthcare, Abu Dhabi, United Arab Emirates., Koshy A; Group42 Healthcare, Abu Dhabi, United Arab Emirates., Yang H; BGI-Shenzhen, Shenzhen, 518083, Guangdong, China., Xu X; BGI-Shenzhen, Shenzhen, 518083, Guangdong, China., Wang J; BGI-Shenzhen, Shenzhen, 518083, Guangdong, China., Xiao P; Group42 Healthcare, Abu Dhabi, United Arab Emirates., Al Kaabi N; SEHA, Abu Dhabi Health Services Co., Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates., Fasihuddin MS; SEHA, Abu Dhabi Health Services Co., Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates., Selvaraj FA; SEHA, Abu Dhabi Health Services Co., Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates., Weber S; SEHA, Abu Dhabi Health Services Co., Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates., Al Hosani FI; Department of Health, Abu Dhabi, United Arab Emirates., Liu S; BGI-Shenzhen, Shenzhen, 518083, Guangdong, China. liusiyang@bgi.com.; School of Public Health (Shenzhen), Sun Yat-sen University, Shenzhen, 510006, Guangdong, China. liusiyang@bgi.com., Zaher WA; Group42 Healthcare, Abu Dhabi, United Arab Emirates. Walid.Zaher@g42.ai.

Publikováno v: Scientific reports [Sci Rep] 2021 Sep 15; Vol. 11 (1), pp. 18728. Date of Electronic Publication: 2021 Sep 15.

Understanding perception and acceptance of Sinopharm vaccine and vaccination against COVID-19 in the UAE.

Autor: Ahamed F; G42 Health Care, Masdar City, Abu Dhabi, UAE., Ganesan S; G42 Health Care, Masdar City, Abu Dhabi, UAE. subhashini.g@g42.ai., James A; YouGov, Canyan Business center, Barsha Heights, Dubai, UAE., Zaher WA; G42 Health Care, Masdar City, Abu Dhabi, UAE.; College of Medicine and Health Sciences United Arab Emirates University (UAEU), Al Ain, UAE.

Publikováno v: BMC public health [BMC Public Health] 2021 Aug 30; Vol. 21 (1), pp. 1602. Date of Electronic Publication: 2021 Aug 30.